Physician profile
Sara Hawk
NPI 1780394205
$954.92
in general payments reported to CMS, 2019-2025
10 companies · $460 in 2025
The $460 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $260 · 2024: $235 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $954.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $239.64 | 2023-2025 | Lifevest |
| Heartflow, INC. | $194.29 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $135.77 | 2023-2025 | Camzyos |
| Abbott Laboratories | $126.70 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Actelion Pharmaceuticals US, INC. | $122.17 | 2024 | Uptravi, Opsumit |
| Pfizer INC. | $49.94 | 2023 | |
| Edwards Lifesciences Corporation | $32.83 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Alnylam Pharmaceuticals INC. | $18.41 | 2025 | Amvuttra |
| Scpharmaceuticals INC. | $17.86 | 2023 | |
| Merck Sharp & Dohme LLC | $17.31 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Hawk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.